FDA Inspection
Cis Bio InternationalCis Bio International – FDA Inspection, Dec 16, 2022
Record Details
This FDA Inspection record concerns Cis Bio International, with an inspection on December 16, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Cis Bio International
- Inspection Date
- December 16, 2022
- Product Type
- Drugs
View Company Profile
ID · 674f3fb1-32c6-4969-8c38-129fd48ada00
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1192908
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
8- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.180(e)(1)Review of representative number of batches
- 21 CFR 211.84(b)Representative Samples Criteria
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.165(f)Failing drug products not rejected
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cis Bio International
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 26, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 31, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cis Bio International
- FDA Inspection 1279816 - 2024-01-26
- FDA Inspection 1135393 - 2020-01-31
- FDA Inspection 904704 - 2014-11-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.